Member Info for Steveiom

Exactly TradingLad, I'm 100% confident that the BOD of TEK would never break any disclosure rules or deliberately mislead us shareholders. Like I said I'm happy to let the regulator look into, I'm sure we'll establish why they didn't need to tell us about the clinical trial and that will be the end of it. You never know they might actually learn something new from all this and improve communication.

On a positive note I did get another email today from the FCA regarding my concerns and I guess the concerns of many others regarding the lack of information about the trial results.
Could be something or nothing. Please see below section from today's reply. If TEK have done nothing wrong then I'm happy to keep it zipped but I'd rather the regulator decide that at the moment than the BOD.

"Thank you for raising your concerns with us. We are reviewing the issues that you have brought to our attention with a view to determining whether it is appropriate for us to exercise any of our statutory powers. As part of such reviews we may use the information gathering powers available to us to seek further information from the subjects of the enquiry and reach out to other agencies as appropriate.

Once we have completed our review, we will consider whether it is appropriate for the FCA to launch a formal investigation via its Enforcement Division, whether some other form of intervention is required or whether the case should be closed with no action"

TopCatz I'm hoping that they clear this up but in my humble opinion we may dealing with two issues here.
The FDA want 15 units to test which is fair enough such a test for a medical device should take no longer than 6 months. They need to ensure the device does what it says, provide high levels of oxygen ect.
The other trial was a test for self use, can people follow instructions safely and use the device.
If they can use it, it's considered a pass and this information would be given to the FDA.
So the FDA need to approve the device, does it work, is it reliable, then they would consider passing it for self use where there is a huge market worth millions.
IMHO there are two tests here, and according to the clinical trial website one of them has concluded. I'm no expert on this and clarity from TEK would be appreciated otherwise we'll all just lose faith in them.

https://www.clinicaltrials.gov/ct2/show/NCT04299178
Guys I would encourage anyone with an interest in TEK or Belluscura to check out the reasons why results are not posted and read into it what you will. The clinical trial website gives very clear reasons as to why the results may be not on show.
Was the trial a flop, if so why after all the previous delays, if it was a success and everyone tested could use the device why have they not told us. I seriously hope they don't hide behind price sensitive information bulls**t and answer what are very polite and respectful questions.

I'm not holding out much hope of the SP blasting upwards come Tuesday morning. Free bags if crisps anyone? I did email Hanks Brokerage the other day to find out if I could try any products that are already using the MicroSalt. It would have been good to see who might be giving it a blast especially if it's been used in ready meals ECT. Got an email back from Mike Marrotte from Salarius.
I will reply again with the same email asking where I can try some products that the salt may be being used but in all honesty judging by their response I get the impression that they can't point me in the direction to where it's being used which does not hold well for sales of the product.
Their lack of communication and transparency is becoming a huge concern. Hopefully the FCA will establish a few things over the Belluscura trial and give them what for.

I agree the SP would have been hammered TLad but would it also give those in the know to dump a few at a reasonable price. Same as if the trial had been a success and they and their pals were the only ones to know, well they could load up prior to releasing the news, I guess that's the reason why news needs to be released as early as possible. I'm in here still with a good few quid and still up, but I think we should all be a good bit more up than we currently are. At least this BB is pretty decent and we all respect and do some research. GLA

All good points made regarding communication. You only have to look at SNG this week informing their shareholders if the outcome from their trial and what it did to the SP. We're they obligated to tell their shareholders.....I think yes. They still need more trials and approval but it was price sensitive information that they could not keep to themselves. This is exactly what TEK and Belluscura should have done from February. The only thing I can think of as to why there has been no news is that the trial was pulled, no results, no need to release information, I'd love to be proved wrong but I can't find an RNS to tell us there was a userbility trial. Help me out guys, did they tell us about the trial in February and if so when? Cheers.

Guys let's not forget the FDA during COVID pulled out all the stops to speed up the approval process with Emergency Use Approval. This was like a come and get it invitation but it looks like they were too busy to accept it.

Given the continued silence from the BOD does anyone expect that all the questions that have been asked will actually be answered. If we continue this way the AGM and Q&A is only going to make the situation worse. They believe that they are not obliged to tell shareholders the results of the trial and given the current closed shop with other news it's highly likely we aren't going to be told anything that we don't already know.

I just hope it's the kick that TEK need to get their act together. On another note I hope they don't release another RNS containing Jack S H I T tomorrow or the SP will be back around the 4p area very quickly.

They only got my email yesterday but got back quite quickly which was appreciated. They are looking into what FCA guidance should be followed when it comes to the dissemination of information to shareholders. I was also sent the following link by them.
https://www.handbook.fca.org.uk/handbook/DTR/6/?view=chapter
If I'm wrong then happy days but I do believe that any information relating to a clinical trial that could be viewed as price sensitive then this needs to be shared as soon as it is known. I'm happy to keep everyone updated in due course.

Just letting you all know that the FCA have got back to me in relation to my concerns over TEK not informing shareholders of the results of the user trial in February. My concerns are that this is price sensitive information and as such I believe they cannot sit on this and use it to their own gain either by purchasing shares or dumping shares depending on the results. I'm quite happy for them to look into the matter and decide if it is acceptable behavior on the part of the company.
As for the RNS today, it's pants! No news really, nothing that Lucyd would not tell you if you asked, in fact I was told more when I asked a few questions, including about debt and what is owed to the American football dude.

Can't really see much in that RNS that a little bit of research wouldn't have provided. I don't believe it's going to make the SP fly but it's a product that has potential. More importantly we need to know what the f*** is going on elsewhere.

Totally agree Adamsky, if that trial went ahead as planned and as stated on the clinical trial website why have we not been told the outcome. Even more so if it is price sensitive information the BOD cannot keep the results to themselves regardless of whether the device passed the userbility test or not. Any price sensitive information only known to the directors puts them and their mates at a very clear advantage to us private investors. I've raised the matter with the FCA but I'm not holding my breath given this is the AIM wild west. Hopefully we will get a raft of news prior to next week starting tomorrow. We should not have to keep digging and digging for news that should be released as an RNS. Fingers crossed they get the message loud and clear and up their game when it comes to communication.

After asking pretty much the same as everyone else is wanting to ask the below was the reply.
Many thanks for your continued interest and support for TEK.


"Thanks for your questions , please appreciate that we cant answer you individually as we need to update the market and investor as a whole through the RNS systems and other IR Initiatives.
Rest assured we will be updating shareholders as and when necessary, and plan to have an investor call with Q&As which will give you a chance to air your thoughts."
Plus I had similar from Belluscura.

Good luck with them Adamsky. They have made it very clear that all we will be told is what is already in the public domain. A very sad situation unless they release some news prior to the meeting and Q&A session but don't hold your breath.

Taken from the Lucyd corporate update. Still cannot believe how crap TEK are at sharing news with us all. Note they claim thousands of pairs of glasses sold. I wonder what that actually equates to?
"It’s been about two and a half years since Lucyd was founded, and a good part of its progress was made possible by our community. That progress took the shape of hundreds of pairs of glasses tested and thousands sold, the development of three new product lines of smart eyewear, engaging in cutting-edge AR research with true leaders in the field, the development and filing of four new utility patents and seventeen design patents, the addition of Richard Sherman as brand ambassador, and building prescription eyewear and Bluetooth technology supply chains to source the most advanced components."

Bit more than a tree shake, they don't need to shake the tree the SP is dropping for one reason only and that's the incompetence of the BOD in communicating news to those that matter. Hopefully my email to the FCA will give them a kick up the bum, I doubt it but it's worth a go.

Dmonies the blame is firmly on the shoulders of the BOD complete shambles on their part. This Q&A is not going to do anything to shore up the SP as they have already made it crystal that they will not be giving out anything that isn't already in the public domain. I really hope those of you sitting on a high average manage to reduce your losses.

I've just emailed the FCA, I firmly believe that the independent trial and the results from it give the BOD and employees of TEK an unfair advantage knowing the results of that test. Yes it does not constitute FDA approval but it is information that would give you an edge when deciding to sell or buy the shares. I'm happy to let the FCA decide now on the rights and wrongs because I'm suck of asking questions and not getting any answers.